ResMed Inc. (RMD)
$
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
9
8
7
6
5
4
3
2
1
0
About
Business overview of ResMed Inc. (RMD)
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Key Insights
Critical company metrics and information
Share Price
$241.41Market Cap
$35.44 BillionTotal Outstanding Shares
146.80 Million SharesTotal Employees
9,980Dividend
$0.53 Per Share QuarterlyIPO Date
June 2, 1995SIC Description
Surgical & Medical Instruments & ApparatusHomepage
https://www.resmed.com
Historical Stock Splits
If you bought 1 share of RMD before October 3, 2005, you'd have 4 shares today.
Execution Date | Split Amount |
---|---|
August 31, 2010 | 2-for-1 |
October 3, 2005 | 2-for-1 |
Cash Flow Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Net Cash Flow, Continuing | $202.94 Million |
Net Cash Flow From Financing Activities | $-1.12 Billion |
Net Cash Flow From Operating Activities | $1.44 Billion |
Net Cash Flow From Investing Activities | $-118.66 Million |
Net Cash Flow | $217.26 Million |
Net Cash Flow From Investing Activities, Continuing | $-118.66 Million |
Net Cash Flow From Financing Activities, Continuing | $-1.12 Billion |
Net Cash Flow From Operating Activities, Continuing | $1.44 Billion |
Exchange Gains/Losses | $14.32 Million |
Income Statement
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Net Income/Loss Attributable To Parent | $1.11 Billion |
Nonoperating Income/Loss | $-42.10 Million |
Cost Of Revenue | $2.04 Billion |
Diluted Average Shares | $442.60 Million |
Diluted Earnings Per Share | $7.55 |
Research and Development | $311.34 Million |
Net Income/Loss Available To Common Stockholders, Basic | $1.11 Billion |
Operating Expenses | $1.35 Billion |
Other Operating Expenses | $109.67 Million |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
Operating Income/Loss | $1.42 Billion |
Benefits Costs and Expenses | $3.43 Billion |
Preferred Stock Dividends And Other Adjustments | $0.00 |
Revenues | $4.81 Billion |
Selling, General, and Administrative Expenses | $933.24 Million |
Income/Loss From Continuing Operations After Tax | $1.11 Billion |
Income Tax Expense/Benefit | $263.22 Million |
Income/Loss From Equity Method Investments | $3.01 Million |
Basic Average Shares | $440.92 Million |
Costs And Expenses | $3.43 Billion |
Basic Earnings Per Share | $7.56 |
Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
Net Income/Loss | $1.11 Billion |
Gross Profit | $2.77 Billion |
Income/Loss From Continuing Operations Before Tax | $1.38 Billion |
Income/Loss Before Equity Method Investments | $1.37 Billion |
Balance Sheet
October 1, 2023 to September 30, 2024
Metric | Value |
---|---|
Liabilities | $2.03 Billion |
Inventory | $917.98 Million |
Assets | $7.22 Billion |
Equity | $5.20 Billion |
Equity Attributable To Noncontrolling Interest | $0.00 |
Noncurrent Assets | $4.58 Billion |
Accounts Payable | $249.28 Million |
Other Non-current Assets | $4.02 Billion |
Current Liabilities | $904.08 Million |
Fixed Assets | $560.21 Million |
Current Assets | $2.64 Billion |
Noncurrent Liabilities | $1.12 Billion |
Long-term Debt | $667.58 Million |
Equity Attributable To Parent | $5.20 Billion |
Other Non-current Liabilities | $455.73 Million |
Liabilities And Equity | $7.22 Billion |
Other Current Liabilities | $654.80 Million |
Other Current Assets | $1.72 Billion |
Historical Dividends
Current dividend: $0.53 Per Share Quarterly
Announcement Date | Payment Date | Record Date | Amount | Frequency |
---|---|---|---|---|
Oct 24, 2024 | Dec 12, 2024 | Nov 7, 2024 | $0.53 | Quarterly |
Aug 1, 2024 | Sep 19, 2024 | Aug 15, 2024 | $0.53 | Quarterly |
Apr 25, 2024 | Jun 13, 2024 | May 9, 2024 | $0.48 | Quarterly |
Jan 24, 2024 | Mar 14, 2024 | Feb 8, 2024 | $0.48 | Quarterly |
Oct 26, 2023 | Dec 14, 2023 | Nov 9, 2023 | $0.48 | Quarterly |
Aug 3, 2023 | Sep 21, 2023 | Aug 17, 2023 | $0.48 | Quarterly |
Apr 27, 2023 | Jun 15, 2023 | May 11, 2023 | $0.44 | Quarterly |
Jan 26, 2023 | Mar 16, 2023 | Feb 9, 2023 | $0.44 | Quarterly |
Oct 27, 2022 | Dec 15, 2022 | Nov 10, 2022 | $0.44 | Quarterly |
Aug 11, 2022 | Sep 22, 2022 | Aug 18, 2022 | $0.44 | Quarterly |
Apr 28, 2022 | Jun 16, 2022 | May 12, 2022 | $0.42 | Quarterly |
Jan 27, 2022 | Mar 17, 2022 | Feb 10, 2022 | $0.42 | Quarterly |
Oct 28, 2021 | Dec 16, 2021 | Nov 11, 2021 | $0.42 | Quarterly |
Aug 5, 2021 | Sep 23, 2021 | Aug 19, 2021 | $0.42 | Quarterly |
Apr 29, 2021 | Jun 17, 2021 | May 13, 2021 | $0.39 | Quarterly |
Jan 28, 2021 | Mar 18, 2021 | Feb 11, 2021 | $0.39 | Quarterly |
Oct 29, 2020 | Dec 17, 2020 | Nov 12, 2020 | $0.39 | Quarterly |
Aug 5, 2020 | Sep 24, 2020 | Aug 20, 2020 | $0.39 | Quarterly |
Apr 30, 2020 | Jun 18, 2020 | May 14, 2020 | $0.39 | Quarterly |
Jan 30, 2020 | Mar 19, 2020 | Feb 13, 2020 | $0.39 | Quarterly |
Oct 24, 2019 | Dec 12, 2019 | Nov 7, 2019 | $0.39 | Quarterly |
Jul 25, 2019 | Sep 19, 2019 | Aug 15, 2019 | $0.39 | Quarterly |
May 2, 2019 | Jun 13, 2019 | May 9, 2019 | $0.37 | Quarterly |
Jan 24, 2019 | Mar 14, 2019 | Feb 7, 2019 | $0.37 | Quarterly |
Oct 25, 2018 | Dec 13, 2018 | Nov 8, 2018 | $0.37 | Quarterly |
Aug 2, 2018 | Sep 20, 2018 | Aug 16, 2018 | $0.37 | Quarterly |
Apr 26, 2018 | Jun 14, 2018 | May 10, 2018 | $0.35 | Quarterly |
Jan 23, 2018 | Mar 15, 2018 | Feb 8, 2018 | $0.35 | Quarterly |
Oct 26, 2017 | Dec 14, 2017 | Nov 9, 2017 | $0.35 | Quarterly |
Aug 1, 2017 | Sep 21, 2017 | Aug 17, 2017 | $0.35 | Quarterly |
Apr 27, 2017 | Jun 15, 2017 | May 11, 2017 | $0.33 | Quarterly |
Jan 23, 2017 | Mar 16, 2017 | Feb 9, 2017 | $0.33 | Quarterly |
Oct 25, 2016 | Dec 15, 2016 | Nov 10, 2016 | $0.33 | Quarterly |
Jul 28, 2016 | Sep 22, 2016 | Aug 18, 2016 | $0.33 | Quarterly |
Apr 26, 2016 | Jun 16, 2016 | May 19, 2016 | $0.3 | Quarterly |
Jan 21, 2016 | Mar 17, 2016 | Feb 11, 2016 | $0.3 | Quarterly |
Oct 22, 2015 | Dec 17, 2015 | Nov 19, 2015 | $0.3 | Quarterly |
Jul 30, 2015 | Sep 17, 2015 | Aug 20, 2015 | $0.3 | Quarterly |
Apr 23, 2015 | Jun 18, 2015 | May 21, 2015 | $0.28 | Quarterly |
Jan 22, 2015 | Mar 19, 2015 | Feb 12, 2015 | $0.28 | Quarterly |
Oct 23, 2014 | Dec 18, 2014 | Nov 20, 2014 | $0.28 | Quarterly |
Jul 31, 2014 | Sep 18, 2014 | Aug 21, 2014 | $0.28 | Quarterly |
Apr 23, 2014 | Jun 17, 2014 | May 20, 2014 | $0.25 | Quarterly |
Jan 23, 2014 | Mar 19, 2014 | Feb 19, 2014 | $0.25 | Quarterly |
Oct 23, 2013 | Dec 18, 2013 | Nov 19, 2013 | $0.25 | Quarterly |
Aug 1, 2013 | Sep 17, 2013 | Aug 20, 2013 | $0.25 | Quarterly |
Apr 25, 2013 | Jun 18, 2013 | May 21, 2013 | $0.17 | Quarterly |
Jan 24, 2013 | Mar 19, 2013 | Feb 19, 2013 | $0.17 | Quarterly |
Oct 25, 2012 | Dec 18, 2012 | Nov 20, 2012 | $0.17 | Quarterly |
Related Companies
View additional S&P 500 companies similar to ResMed Inc. (RMD)
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
ⓒ 2024 Financhle. All Rights Reserved.